[SYRE] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
30-Sep-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- 15.80%
YoY- 16.41%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 13,696 0 0 0 0 0 0 -
PBT -6,738 -18,218 -22,714 -18,033 -21,418 -18,728 -21,495 -53.88%
Tax 92 0 0 0 0 0 0 -
NP -6,830 -18,218 -22,714 -18,033 -21,418 -18,728 -21,495 -53.46%
Tax Rate - - - - - - - -
Total Cost 20,526 18,218 22,714 18,033 21,418 18,728 21,495 -3.03%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin -49.87 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS -2.60 -6.94 0.00 -7.24 -10.11 -14.15 0.00 -
EPS Diluted -2.60 -6.94 0.00 -7.24 -10.11 -14.15 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.